Gilde Healthcare company ADCendo appoints Dominik Mumberg, PHD, as Chief Scientific Officer
Brings in-depth R&D expertise in oncology, including ADCs, targeted radiotherapies, immuno-oncology and small molecules Adcendo building a world class team of experienced biotech & pharma executives and renowned leaders in the ADC field Adcendo ApS (“Adcendo”), a therapeutics company focused on the development of breakthrough antibody-drug conjugates...